Pharma

Your Article Summary

See Latest Articles

Antigenics Reports Second Quarter 2009 Financial Results
Antigenics, 08/03/09

Antigenics Inc. reported results today for the quarter ended June 2009. The company incurred a net loss attributable to common stockholders of $12.3 million, or $0.17 per share, basic and diluted, for the second quarter of 2009, compared with a net loss attributable to common stockholders of $12.5 million, or $0.19 per share, basic and diluted, in the second quarter of 2008. For the six months ended June 2009, the company incurred a net loss attributable to common stockholders of $22.0 million, or $0.31 per share, basic and diluted, compared with a net loss attributable to common stockholders of $24.0 million, or $0.40 per share, basic and diluted, for the comparable period in 2008. The company's net cash burn for the three months ended June 2009 and 2008 was $5.7 million and $6.9 million, respectively.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

VA Re-Ups with QuadraMed
HealthDataManagement, 12/18/09

Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

 See all of Financial Reports